Sex Representation in Clinical Trials Associated with FDA Cancer Drug Approvals Differs Between Solid and Hematologic MalignanciesShehara Mendis, Jonathan M. Loree|The Oncologist|2020Cited by 29
Abstract CT115: Phase 1b open-label, non-randomized, multi-center clinical trial of intratumoral IVX037 in combination with sintilimab (anti-PD1) in patients with advanced microsatellite stable (MSS) colorectal,gastroesophageal or ovarian cancerMark Wong, Jia Liu, Timothy Price et al.|Cancer Research|2025Cited by 0